Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2024 from OUS - Department of Medical Biochemistry

28 publications found

Amundsen EK, Ihle-Hansen H, Kraglund KL, Hagberg G (2024)
Acute ischemic stroke and measurement of apixaban and rivaroxaban: an observational cohort implementation study
Res Pract Thromb Haemost, 8 (1), 102307
DOI 10.1016/j.rpth.2023.102307, PubMed 38314168

Arntsen V, Jamali A, Sikiric A, Kristensen E, Tangeraas T, Kupliauskiene G, Stefansdottir S, Bindoff LA, Sand T, Brodtkorb E (2024)
Utility and limitations of EEG in the diagnosis and management of ALDH7A1-related pyridoxine-dependent epilepsy. A retrospective observational study
Front Neurol, 15, 1355861
DOI 10.3389/fneur.2024.1355861, PubMed 38419708

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572

Bjerager J, Magnø M, Chen X, Belmouhand M, Aass HCD, Reppe S, Heegaard S, Larsen M, Utheim TP (2024)
Heritability of tear fluid cytokines in healthy twins
Ocul Surf, 32, 145-153 (in press)
DOI 10.1016/j.jtos.2024.02.005, PubMed 38387783

Brobak KM, Halvorsen LV, Aass HCD, Søraas CL, Aune A, Olsen E, Bergland OU, Rognstad S, Blom KB, Birkeland JAK, Høieggen A, Larstorp ACK, Solbu MD (2024)
Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage
Blood Press, 33 (1), 2323980
DOI 10.1080/08037051.2024.2323980, PubMed 38606688

Brun MK, Gehin JE, Bjørlykke KH, Warren DJ, Klaasen RA, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Jahnsen J, Bolstad N, Jørgensen KK, Haavardsholm EA, Goll GL, Syversen SW (2024)
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Lancet Rheumatol, 6 (4), e226-e236
DOI 10.1016/S2665-9913(23)00341-7, PubMed 38402891

Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S (2024)
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812

Dahl J, Ormstad H, Aass HCD, Malt UF, Andreassen OA (2024)
Changes in pain during a depressive episode and relationship to cytokine levels in major depressive disorder
Nord J Psychiatry, 78 (3), 181-188
DOI 10.1080/08039488.2023.2290654, PubMed 38251060

Enayati S, Chang K, Lennikov A, Yang M, Lee C, Ashok A, Elzaridi F, Yen C, Gunes K, Xie J, Cho KS, Utheim TP, Chen DF (2024)
Optimal transcorneal electrical stimulation parameters for preserving photoreceptors in a mouse model of retinitis pigmentosa
Neural Regen Res, 19 (11), 2543-2552
DOI 10.4103/1673-5374.392888, PubMed 38526290

Gregersen I, Scarth ME, Abdullah R, Thorsby PM, Hauger LE, Haugaa KH, Sagen EL, Michelsen AE, Ueland T, Edvardsen T, Aukrust P, Almaas VM, Bjørnebekk AK, Halvorsen B (2024)
Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of Anabolic-Androgenic Steroids
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae126, PubMed 38573232

Gundersen M, Jensen P, Nilsen C, Yazdani M, Utheim Ø, Sandås EM, Rootwelt H, Gundersen KG, Elgstøen KBP (2024)
Method Development for Omics Analyses using Schirmer Strips
Curr Eye Res, 1-9 (in press)
DOI 10.1080/02713683.2024.2335271, PubMed 38567868

Hadad R, Hedengran A, Barnils A, Petrovski G, Cvenkel B, Utheim TP, Dartt DA, Heegaard S, Kolko M (2024)
Effect of chlorhexidine, povidone-iodine and betadine antiseptic eye drops on cultured human conjunctival goblet cell survival
Acta Ophthalmol (in press)
DOI 10.1111/aos.16684, PubMed 38553957

Henriksen HCB, Havnes IA, Jørstad ML, Abdullah R, Thorsby PM, Hauger LE, Edvardsen T, Haugaa KH, Almaas VM, Bjørnebekk A (2024)
Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study
Scand J Med Sci Sports, 34 (1), e14554
DOI 10.1111/sms.14554, PubMed 38268076

Ho AVT, Øvensen E, Lilja D, Toska K, Grenager O, Kristiansen K, Wesche J (2024)
Changes in electrodermal activity following sympathicotomy in hyperhidrosis patients
Front Surg, 11, 1358357
DOI 10.3389/fsurg.2024.1358357, PubMed 38529470

Huynh TM, Falk RS, Hellebust TP, Dale E, Astrup GL, Hjermstad MJ, Malinen E, Bjordal K, Kiserud CE, Herlofson BB, Nome R, Amdal CD (2024)
Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
Radiother Oncol, 195, 110231 (in press)
DOI 10.1016/j.radonc.2024.110231, PubMed 38518958

Jensen P, Nilsen C, Gundersen M, Gundersen KG, Potvin R, Gazerani P, Chen X, Utheim TP, Utheim ØA (2024)
A Preservative-Free Approach - Effects on Dry Eye Signs and Symptoms After Cataract Surgery
Clin Ophthalmol, 18, 591-604
DOI 10.2147/OPTH.S446804, PubMed 38435373

Juvodden HT, Alnæs D, Agartz I, Andreassen OA, Server A, Thorsby PM, Westlye LT, Knudsen-Heier S (2024)
Cortical thickness and sub-cortical volumes in post-H1N1 narcolepsy type 1: A brain-wide MRI case-control study
Sleep Med, 116, 81-89
DOI 10.1016/j.sleep.2024.02.031, PubMed 38432031

Khan AZ, Ueland HO, Bohman E, Tønseth KA, Utheim TP (2024)
Ectropion
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0309, PubMed 38258716

Lukina P, Andersen IL, Eggen PT, Mjønes PG, Rønne E, Bolstad N, Klaasen RA, Warren DJ, Iversen R, Hveem K, Bernklev T, Jelsness-Jørgensen LP, Pedersen L, Jonkers I, Lagergren P, Sollid LM, Lundin K, Ness-Jensen E (2024)
Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients
BMJ Open, 14 (1), e077131
DOI 10.1136/bmjopen-2023-077131, PubMed 38195172

Malmin A, Thomseth VM, Førland PT, Aass HCD, Reppe S, Olsen MVT, Lindtjørn B, Chen X, Haugen IBK, Utheim TP, Forsaa VA (2024)
Tear cytokine levels are reduced in patients treated with intravitreal injections
Ocul Surf, 32, 222-226 (in press)
DOI 10.1016/j.jtos.2024.03.004, PubMed 38490478

Martínez-Feito A, Plasencia-Rodríguez C, Novella-Navarro M, Gehin JE, Hernández-Breijo B, Brenis CM, Villalba-Yllán A, Fernández E, Monjo-Henry I, Pascual-Salcedo D, Nozal P, Balsa A (2024)
Influence of rheumatoid factor on serum drug levels of tumour necrosis factor inhibitors with different structures in rheumatoid arthritis
Clin Exp Rheumatol (in press)
DOI 10.55563/clinexprheumatol/ig40gm, PubMed 38197184

Naqvi M, Fineide F, Utheim TP, Charnock C (2024)
Culture- and non-culture-based approaches reveal unique features of the ocular microbiome in dry eye patients
Ocul Surf, 32, 123-129 (in press)
DOI 10.1016/j.jtos.2024.02.002, PubMed 38354907

Nøland ST, Magnø MS, Utheim TP, Chen X (2024)
Sex Differences in the Prevalence of Meibomian Gland Dysfunction: A Mini Review
Curr Eye Res, 49 (5), 447-457
DOI 10.1080/02713683.2023.2301325, PubMed 38196124

Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S (2024)
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial
Br J Cancer (in press)
DOI 10.1038/s41416-024-02696-6, PubMed 38664577

Steenholdt C, Lorentsen RD, Petersen PN, Widigson ES, Kloft C, Klaasen RA, Brynskov J (2024)
Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease
J Gastroenterol Hepatol (in press)
DOI 10.1111/jgh.16518, PubMed 38380724

Tashbayev B, Chen X, Utheim TP (2024)
Chalazion Treatment: A Concise Review of Clinical Trials
Curr Eye Res, 49 (2), 109-118
DOI 10.1080/02713683.2023.2279014, PubMed 37937798

Wiken TH, Høivik ML, Anisdahl K, Buer L, Warren DJ, Bolstad N, Hagen M, Moum BA, Medhus AW (2024)
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study
Crohns Colitis 360, 6 (1), otae013
DOI 10.1093/crocol/otae013, PubMed 38544907

Yazdani M (2024)
Cellular and Molecular Responses to Mitochondrial DNA Deletions in Kearns-Sayre Syndrome: Some Underlying Mechanisms
Mol Neurobiol (in press)
DOI 10.1007/s12035-024-03938-7, PubMed 38224444

0.14s